Evaluation of serum level of carnitine in HIV-positive individuals and its possible explanatory factors

By Salamzadeh Jamshid   Rezaee Haleh   Khalili Hossein   Jafari Sirous   Abdollahi Alireza  

Future Virology, Vol. 7, Iss. 10, 2012-10 ,pp. : 1021-1028

Future Medicine

Access to resources Recommend Favorite

Drug Treatment of Depression in HIV-Positive Patients: Safety Considerations

By Pieper Andrew A.  

Drug Safety, Vol. 28, Iss. 9, 2005-01 ,pp. : 753-762

Adis International

Access to resources Recommend Favorite

A Comparison of the Therapeutic Plan Costs in the Treatment of HIV-Positive Patients

By Sabbatani S.  

Clinical Drug Investigation, Vol. 23, Iss. 7, 2003-01 ,pp. : 473-478

Adis International

Access to resources Recommend Favorite

Safety Considerations in Drug Treatment of Depression in HIV-Positive Patients: An Updated Review

By Watkins Crystal C.  

Drug Safety, Vol. 34, Iss. 8, 2011-08 ,pp. : 623-639

Adis International

Access to resources Recommend Favorite

Relationships Between Exposure to Saquinavir Monotherapy and Antiviral Response in HIV-Positive Patients

By Gieschke R.   Fotteler B.   Buss N.   Steimer J-L.  

Clinical Pharmacokinetics, Vol. 37, Iss. 1, 1999-07 ,pp. : 75-86

Adis International

Access to resources Recommend Favorite